{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T14:57:32Z","timestamp":1771167452639,"version":"3.50.1"},"reference-count":13,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2018-0002_s_999_w2aab3b7b1b1b6b1aab1c16b1Aa\">\n                    <jats:title id=\"d440067e3244_w2aab3b7b1b1b6b1aab1c16b1aAa\">Background<\/jats:title>\n                    <jats:p>The severity of polycystic ovarian syndrome (PCOS) has been clearly associated with insulin resistance, obesity and metabolic syndrome. The purpose of the present cross-sectional study is to investigate whether mild hypercholesterolemia alters the biochemical and clinical profile of PCOS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2018-0002_s_998_w2aab3b7b1b1b6b1aab1c16b2Aa\">\n                    <jats:title id=\"d440067e3253_w2aab3b7b1b1b6b1aab1c16b2aAa\">Methods<\/jats:title>\n                    <jats:p>Our study is based on a prospectively collected population of women of reproductive age who were diagnosed with PCOS according to the definition of the Rotterdam European Society of Human Reproduction and Embryology\/American Society for Reproductive Medicine (ASRM\/ESHRE) criteria. For the correlation analysis we used the non-parametric Spearman\u2019s rank correlation coefficient. Partial correlation was also performed to control for potential confounders observed in the univariate analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2018-0002_s_997_w2aab3b7b1b1b6b1aab1c16b3Aa\">\n                    <jats:title id=\"d440067e3262_w2aab3b7b1b1b6b1aab1c16b3aAa\">Results<\/jats:title>\n                    <jats:p>Overall, 235 patients were included. Their mean age ranged between 14 and 45 years old and the body mass index (BMI) between 17 and 54. Women with mild hypercholesterolemia had a higher BMI and their fasting insulin was increased as well as indices of insulin resistance [Homeostatic model assessment (HOMA), quantitative insulin sensitivity check index (QUICKI), Matsuda index] compared to women with PCOS with normal cholesterol levels. Correlation statistics suggested that the effect of serum lipids on the hormonal profile of patients was weak. Both low-density lipoprotein (LDL) and high-density lipoprotein (HDL) exerted a significant mild negative correlation to glucose and insulin. However, after controlling the results for BMI and age (the two variables that were found significantly different in the univariate analysis) we observed that this effect was non-significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2018-0002_s_996_w2aab3b7b1b1b6b1aab1c16b4Aa\">\n                    <jats:title id=\"d440067e3271_w2aab3b7b1b1b6b1aab1c16b4aAa\">Conclusion<\/jats:title>\n                    <jats:p>Mild hypercholesterolemia does not affect the hormonal profile of patients with PCOS; hence, to date, there is no evidence to suggest its treatment for the correction of menstrual and hormonal abnormalities in PCOS women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2018-0002","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T18:20:56Z","timestamp":1522347656000},"source":"Crossref","is-referenced-by-count":8,"title":["The impact of mild hypercholesterolemia on glycemic and hormonal profiles, menstrual characteristics and the ovarian morphology of women with polycystic ovarian syndrome"],"prefix":"10.1515","volume":"34","author":[{"given":"Vasilios","family":"Pergialiotis","sequence":"first","affiliation":[{"name":"Third Department of Obstetrics and Gynecology , University of Athens, Attikon University Hospital Athens Greece , Rimini 1 Chaidari , Athens, PC 12461 , Greece , Phone: +302105832244, +306947326459, Fax: 2105326447"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eftihios","family":"Trakakis","sequence":"additional","affiliation":[{"name":"Third Department of Obstetrics and Gynecology , \u201cAttikon\u201d University Hospital, National and Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalampos","family":"Chrelias","sequence":"additional","affiliation":[{"name":"Third Department of Obstetrics and Gynecology , \u201cAttikon\u201d University Hospital, National and Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Papantoniou","sequence":"additional","affiliation":[{"name":"Third Department of Obstetrics and Gynecology , \u201cAttikon\u201d University Hospital, National and Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erifili","family":"Hatziagelaki","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Research Institute and Diabetes Center , \u201cAttikon\u201d Hospital, National and Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2018,3,29]]},"reference":[{"key":"2025121207250580280_j_hmbci-2018-0002_ref_001_w2aab3b7b1b1b6b1ab1b6b1Aa","unstructured":"Ma YM, Li R, Qiao J, Zhang XW, Wang SY, Zhang QF, et al. Characteristics of abnormal menstrual cycle and polycystic ovary syndrome in community and hospital populations. Chin Med J (Engl). 2010;123:2185\u20139.20819662"},{"key":"2025121207250580280_j_hmbci-2018-0002_ref_002_w2aab3b7b1b1b6b1ab1b6b2Aa","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19\u20132514711538","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"2025121207250580280_j_hmbci-2018-0002_ref_003_w2aab3b7b1b1b6b1ab1b6b3Aa","doi-asserted-by":"crossref","unstructured":"Al-Jefout M, Alnawaiseh N, Al-Qtaitat A. Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes. Sci Rep. 2017;7:5339.10.1038\/s41598-017-05717-y28706269","DOI":"10.1038\/s41598-017-05717-y"},{"key":"2025121207250580280_j_hmbci-2018-0002_ref_004_w2aab3b7b1b1b6b1ab1b6b4Aa","doi-asserted-by":"crossref","unstructured":"Rocha MP, Marcondes JA, Barcellos CR, Hayashida SA, Curi DD, da Fonseca AM, et al. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecol Endocrinol. 2011;27:814\u20139.10.3109\/09513590.2010.50885220807166","DOI":"10.3109\/09513590.2010.508852"},{"key":"2025121207250580280_j_hmbci-2018-0002_ref_005_w2aab3b7b1b1b6b1ab1b6b5Aa","doi-asserted-by":"crossref","unstructured":"Rahmanpour H, Jamal L, Mousavinasab SN, Esmailzadeh A, Azarkhish K. Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents. J Pediatr Adolesc Gynecol. 2012;25:208\u201312.10.1016\/j.jpag.2012.02.00422578482","DOI":"10.1016\/j.jpag.2012.02.004"},{"key":"2025121207250580280_j_hmbci-2018-0002_ref_006_w2aab3b7b1b1b6b1ab1b6b6Aa","doi-asserted-by":"crossref","unstructured":"Patel RS, Shah GB. High-fat diet exposure from pre-pubertal age induces PCOS in rats. Reproduction. 2018;155:141\u201351.2919649210.1530\/REP-17-0584","DOI":"10.1530\/REP-17-0584"},{"key":"2025121207250580280_j_hmbci-2018-0002_ref_007_w2aab3b7b1b1b6b1ab1b6b7Aa","doi-asserted-by":"crossref","unstructured":"Alexiou E, Hatziagelaki E, Pergialiotis V, Chrelias C, Kassanos D, Siristatidis C, et al. Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index. Horm Mol Biol Clin Investig. 2017;29:105\u201311.28099123","DOI":"10.1515\/hmbci-2016-0047"},{"key":"2025121207250580280_j_hmbci-2018-0002_ref_008_w2aab3b7b1b1b6b1ab1b6b8Aa","unstructured":"Christodoulopoulou V, Trakakis E, Pergialiotis V, Peppa M, Chrelias C, Kassanos D, et al. Clinical and biochemical characteristics in PCOS women with menstrual abnormalities. J Family Reprod Health. 2016;10:184\u201390.28546817"},{"key":"2025121207250580280_j_hmbci-2018-0002_ref_009_w2aab3b7b1b1b6b1ab1b6b9Aa","doi-asserted-by":"crossref","unstructured":"Trakakis E, Pergialiotis V, Hatziagelaki E, Panagopoulos P, Salloum I, Papantoniou N. Subclinical hypothyroidism does not influence the metabolic and hormonal profile of women with PCOS. Horm Mol Biol Clin Investig. 2017;31. doi:10.1515\/hmbci-2016-0058.28672734","DOI":"10.1515\/hmbci-2016-0058"},{"key":"2025121207250580280_j_hmbci-2018-0002_ref_010_w2aab3b7b1b1b6b1ab1b6c10Aa","doi-asserted-by":"crossref","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. American association of clinical endocrinologists, American college of endocrinology and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome \u2013 Part 2. Endocr Pract. 2015;21:1415\u201326.10.4158\/EP15748.DSCPT2","DOI":"10.4158\/EP15748.DSCPT2"},{"key":"2025121207250580280_j_hmbci-2018-0002_ref_011_w2aab3b7b1b1b6b1ab1b6c11Aa","doi-asserted-by":"crossref","unstructured":"Hayashi N, Akamatsu H, Kawashima M. Establishment of grading criteria for acne severity. J Dermatol. 2008;35:255\u201360.18477223","DOI":"10.1111\/j.1346-8138.2007.00403.x-i1"},{"key":"2025121207250580280_j_hmbci-2018-0002_ref_012_w2aab3b7b1b1b6b1ab1b6c12Aa","doi-asserted-by":"crossref","unstructured":"Wu LL, Norman RJ, Robker RL. The impact of obesity on oocytes: evidence for lipotoxicity mechanisms. Reprod Fertil Dev. 2011;24:29\u201334.22394715","DOI":"10.1071\/RD11904"},{"key":"2025121207250580280_j_hmbci-2018-0002_ref_013_w2aab3b7b1b1b6b1ab1b6c13Aa","doi-asserted-by":"crossref","unstructured":"Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity\u2019s impact. Fertil Steril. 2017;107:840\u20137.10.1016\/j.fertnstert.2017.01.01728292619","DOI":"10.1016\/j.fertnstert.2017.01.017"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/hmbci.ahead-of-print\/hmbci-2018-0002\/hmbci-2018-0002.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2018-0002\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2018-0002\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:25:59Z","timestamp":1765527959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2018-0002\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,29]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,29]]},"published-print":{"date-parts":[[2018,6,26]]}},"alternative-id":["10.1515\/hmbci-2018-0002"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2018-0002","relation":{},"ISSN":["1868-1891","1868-1883"],"issn-type":[{"value":"1868-1891","type":"electronic"},{"value":"1868-1883","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3,29]]},"article-number":"20180002"}}